Understanding how respiratory viruses affect vulnerable populations
Official title: Systems Immunology profiling of respiratory viral infections in vulnerable populations
Funded at Benaroya Research Inst at Virginia Mason · NIH-11295557 · Data updated 2026-11-12
This study is looking at how the immune system reacts to respiratory viruses in older adults and people with health issues, so we can find better ways to treat them, and patients may help by sharing samples or information about their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Benaroya Research Inst at Virginia Mason NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | March 29, 2022 |
| Project end | February 28, 2027 |
| Funding year | 2025 |
| Award (this year) | $237,123 |
| NIH project number | 5U19AI167891-04 |
| Project ID | NIH-11295557 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include individuals from vulnerable populations, such as the elderly or those with chronic health conditions.
✕Less likely to help
Patients who are healthy and do not belong to vulnerable groups may not receive direct benefits from this research.
What this research studies
This research investigates the immune responses to respiratory viral infections in populations that are particularly at risk, such as the elderly or those with underlying health conditions. By profiling the immune system's reaction to these infections, the study aims to identify specific biomarkers and immune pathways that could inform better treatment strategies. Patients may be involved in providing samples or data that will help researchers understand the variations in immune responses among different groups. The approach combines advanced immunological techniques with patient data to create a comprehensive picture of how these infections impact health.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for respiratory viral infections in vulnerable populations.
How similar studies have gone: While the specific approach may be novel, similar research has shown promise in understanding immune responses to infections in at-risk populations.
Where this research is happening
-
Benaroya Research Inst at Virginia Mason
Seattle, United States Active
Researchers
- Principal investigator: Presnell, Scott — Benaroya Research Inst at Virginia Mason
- Study coordinator: Presnell, Scott
Related research
Other NIH-funded projects on the same topics.
-
T cells and the switch from pre-autoimmunity to autoimmune disease
A study following people at risk for type 1 diabetes and people with Down syndrome to understand how certain T cells may shift toward causing autoimmune disease.
-
Genetic and epigenetic control of T cell function in autoimmune disease
This grant aims to understand how genetic and epigenetic changes affect how T cells behave in autoimmune diseases to find ways to reduce harmful immune responses.
-
Immune Tolerance Network (ITN) for immune tolerance therapies across autoimmune and allergic diseases
A national network runs clinical trials to test new immune-tolerance therapies that could help people with autoimmune and allergic diseases.
-
Immune Tolerance Network for safer, more effective immune therapies
A nationwide network tests new immune therapies to help people with autoimmune diseases, allergies, and transplant patients reach better control of their immune system.
-
Immune tolerance research network for safer transplant and autoimmune therapies
A national effort tests new treatments that make the immune system tolerate transplanted organs and fight autoimmune and allergic diseases more safely.
-
Immune Tolerance Network for allergy, autoimmunity, and transplantation
A large NIH program tests new immune-tolerance therapies to help people with autoimmune diseases, allergies, and transplant patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.